New Day Therapeutics provides app-based patient treatment for PTSD and refractory depression using technology and daily, low dose ketamine therapy. Our app and back-end data management enable healthcare providers to manage patient checks efficiently and safely with symptom surveys and dosage instruction. A proprietary provider portal provides AI based dosage management suggestions and the ability to anticipate suicidal ideation prior to tragedy. We also use AI for patient oversight, so we are able toanticipate suicidality prior to crisis. We have several interventions ranging from contact with a nurse practitioner, increased dosages, peer counseling, up to connection with the National Suicide Hotline and even the dispatch of emergency medical service based on geolocation information gathered by the app. exploring new ideas and expanding their horizons.
New Day Therapeutics provides veterans with PTSD and depression with evidence-based medical care through daily app-based symptom checks, data science, and AI
Steve Barns, Founder and CEO,
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.